Cancer drugs whose price reduction was announced in the Union budget are used in a minority of cases while many other chemotherapy drugs used more commonly still remain expensive, doctors said at a ...

Estée Lauder said it now expects to cut between 5,800 and 7,000 positions ... is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech ...

This story was originally published on HR Dive. To receive daily news and insights, subscribe to our free daily HR Dive newsletter. About 52% of U.S. employees said they use artificial ...

Palm Beach Tan, located at 200 N. Airport Road in Jasper, held its ribbon cutting last Wednesday. Palm Beach Tan is owned by Kit Birdsong and Amy Sanford. The business is open Monday through Friday ...

Get the latest car news, reviews, and features.

On Friday, Mayor Buddy Dyer and District 5 Commissioner Shan Rose were among those on hand for a ribbon-cutting at Fern Grove Apartments. The 55+ community is located along W.D. Judge Drive west ...

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The Christian Science Church, and we’ve always been transparent about that. The Church publishes the ...

WELLINGTON – New Zealand said late on Thursday that it would make a commitment that by 2035 the country would have reduced emissions by 51% to 55% compared to 2005 levels. The commitment is part of ...

is seeking $5.6 million in city dollars to bolster the Street to Home initiative — a program city officials say can cut unsheltered homelessness in half by 2026. Street to Home, a multipronged $ ...

If Title 20 funds are cut, the organization stands to lose about $1.9 million — roughly half of its total funding. This comes just months after the Abilene branch expanded its services by taking ...

That was not the case for Jon Scheyer and his Blue Devils (17-2 ... January 28, 2025 At the half, Dontrez Styles is pacing the suddenly poised NC State basketball team in scoring with his 13 ...

Following the FDA’s rejection of Atara Biotherapeutics’ T cell therapy for a transplant-related blood cancer and a related clinical hold, the company has divulged that it will cut about 50% of its ...